ʻO Melon ʻawaʻawa

Anter

• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO ka melon ʻawaʻawa kahi mea kanu i hoʻohana ʻia ma India a me nā ʻāina ʻĀsia ʻē aʻe. Hoʻohana ʻia ka hua a me nā ʻanoʻano e hana i ka lāʻau.

Hoʻohana ka poʻe i ka melon ʻawaʻawa no ka maʻi diabetes, ka momona, ka ʻōpū a me nā pilikia ʻōpū, a me nā ʻano ʻē aʻe he nui, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no ʻO BITTER MELON penei:

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Hana Athletic. Hōʻike ka noiʻi mua i ka lawe ʻana i kahi melon ʻawaʻawa e hoʻoliʻiliʻi i ka luhi i ka poʻe e komo nei i ka hoʻomaʻamaʻa kino kino i nā mahana wela.
• Diabetes. Kūlike ʻole ka noiʻi ʻana. Hōʻike kekahi mau noiʻi e hiki i ka lawe ʻana i ka melon ʻawaʻawa ke hōʻemi i nā pae kō kō a hoʻohaʻahaʻa HbA1c (kahi ana o ka mālama kō kō ʻana i ka manawa) i ka poʻe me ka maʻi diabetes type 2. Akā ʻo kēia mau haʻawina he mau hemahema kekahi. A ʻaʻole ʻae nā noiʻi āpau. Pono nā aʻo kiʻekiʻe e pono ai.
• Prediabetes. Hōʻike ka noiʻi mua ʻaʻole hiki i ka melon ʻawaʻawa ke hoʻemi i ke kō kō i nā poʻe me ka prediabetes.
• ʻO Osteoarthritis. Hōʻike ka noiʻi mua e hōʻemi ka melon ʻawaʻawa i ka nui o nā lāʻau ʻeha e pono ai nā poʻe me ka osteoarthritis. Akā ʻaʻole ia e hoʻomaikaʻi i nā ʻōuli.
• ʻO kahi hui o nā hōʻailona e hoʻonui i ka makaʻi o ka maʻi kō, ka maʻi puʻuwai, a me ka hahau (metabolic syndrome).
• ʻO kahi ʻano maʻi maʻi ʻōpū (ulcerative colitis).
• HIV / AIDS.
• Hoʻopilikia (dyspepsia).
• ʻO ka maʻi o nā ʻōpū e nā parasites.
• Pohaku hakuʻala.
• Maʻi maʻi ate.
• Scaly, ʻili ʻili (psoriasis).
• Ulcer ʻōpū.
• Hoola ʻeha.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka pono o ka melon ʻawaʻawa no kēia mau hoʻohana.

Loaʻa i ka melon ʻawaʻawa kahi kemika e hana e like me ka insulin e kōkua i ka hoʻēmi ʻana i nā pae kō kō.

Ke lawe ʻia e ka waha: ʻO ka melon ʻawaʻawa ia SAFE MAU PONO no ka hapa nui o ka poʻe ke lawe ʻia e ka waha wā pōkole (a i 4 mau mahina). Hoʻokumu paha ka melon ʻawaʻawa i kahi ʻōpū huhū i kekahi poʻe. ʻAʻole ʻike ʻia ka palekana o ka hoʻohana wā lōʻihi o ka melon ʻawaʻawa.

Ke hoʻopili ʻia i ka ʻili: ʻAʻole lawa ka ʻike hilinaʻi e ʻike ai inā palekana ka melon ʻawaʻawa ke hoʻopili ʻia i ka ʻili. Hoʻokumu paha ia i ka hū.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻO ka melon ʻawaʻawa ia POSSIBLY UNSAFE ke lawe ʻia e ka waha i ka wā hāpai. Hoʻomaka kekahi mau kemika i ka melon ʻawaʻawa e hoʻomaka i ke kahe o ka menstrual a ua hōʻeha i nā holoholona. ʻAʻole lawa ka ʻike e pili ana i ka palekana o ka hoʻohana ʻana i nā melon ʻawaʻawa i ka wā e hānai ana i ka umauma. Noho ma ka ʻaoʻao palekana a pale i ka hoʻohana.

Diabetes: Hiki i ka melon ʻawaʻawa ke hoʻohaʻahaʻa i nā pae kō kō. Inā loaʻa ʻoe i ka maʻi diabetes a lawe i nā lāʻau e hoʻohaʻahaʻa i kāu kō kō, ke hoʻohui nei i ka melon ʻawaʻawa e hoʻohaʻahaʻa loa ai kāu kō kō E kiaʻi pono i kāu kō kō.

Glucose-6-phosphate dehydrogenase (G6PD) nele: E hoʻomōhala paha ka poʻe me ka hemahema G6PD i ka "favism" ma hope o ka ʻai ʻana i nā hua melon ʻawaʻawa. ʻO Favism kahi ʻano i kapa ʻia ma hope o ka bean fava, ka mea i manaʻo ʻia e hoʻokumu i "ke koko luhi" (anemia), ʻeha poʻo, kuni, ʻeha o ka ʻōpū, a me ke koma i kekahi poʻe. ʻO kahi kemika i loaʻa i nā ʻano melon ʻawaʻawa e pili ana i nā kemika i nā pī fava. Inā loaʻa iā ʻoe ka hemahema G6PD, pale i ka melon ʻawaʻawa.

ʻOki kino: Aia kekahi hopohopo e komo paha ka melon ʻawaʻawa me ka kaohi kō kō i ka wā a ma hope o ke kaha E hōʻoki i ka hoʻohana ʻana i ka melon ʻawaʻawa ma ka liʻiliʻi he 2 mau pule ma mua o ke kaha ʻana

Kānāwai

E akahele me kēia hui ʻana.

Nā lāʻau no ka maʻi kō (Antidiabetes lāʻau)

Hiki i ka melon ʻawaʻawa ke hōʻemi i nā pae kō kō. Hoʻohana ʻia nā lāʻau diabetes e hoʻohaʻahaʻa i ke kō kō. Lawe i ka melon ʻawaʻawa me nā lāʻau diabetes e hoʻohaʻahaʻa loa i kāu kō kō. E nānā pono i kāu kō kō. Pono e hoʻololi i ka mahele lāʻau o kāu lāʻau diabetes.

ʻO kekahi mau lāʻau no ka maʻi kō, ʻo glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), repaglinide (Prandin), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), a me nā mea ʻē aʻe.

Neʻe ʻia nā lāʻau e nā pauma i nā hunaola (P-Glycoprotein Substrates)

Hoʻoneʻe ʻia kekahi mau lāʻau e nā pauma i nā hunaola. ʻO kahi mea hana i loko o ka melon ʻawaʻawa e hana i kēia mau pauma i mea hana ʻole a hoʻonui i ka lōʻihi o ka noho ʻana o kekahi lāʻau i ke kino. Hoʻonui paha kēia i ka hopena a i ʻole nā ​​hopena ʻaoʻao o kekahi mau lāʻau.
ʻO kekahi mau lāʻau i neʻe ʻia e nā pumps i nā pūnaewele e komo pū me rivaroxaban (Xarelto), apixaban (Eliquis), linagliptin (Tradjenta), etoposide (Toposar), paclitaxel (Taxol), vinblastine (Velban), vincristine (Vincasar), itraconazole (Sporanox), amprenavir (Agenerase), indinavir (Crixivan), nelfinavir (Viracept), saquinavir (Invirase), cimetidine (Tagamet), ranitidine (Zantac), diltiazem (Cardizem), verapamil (Calan), corticosteroids, erythromyine (Eofthinamine) (Allegra), cyclosporine (Sandimmune), loperamide (Imodium), quinidine (Quinidex), a me nā mea ʻē aʻe.

ʻO nā lau nahele a me nā mea hoʻopili e hoʻoliʻiliʻi ai i ke kō kō

Hiki i ka melon ʻawaʻawa ke hoʻohaʻahaʻa i nā pae glucose koko. ʻO ka hoʻohana ʻana ia me nā mea kanu ʻē aʻe a i ʻole nā ​​mea hoʻopihapiha i loaʻa ka hopena like e hoʻoliʻiliʻi haʻahaʻa ai nā pae kō kō. ʻO kekahi mau mea kanu a me nā mea hoʻopihapiha i hiki ke hoʻohaʻahaʻa i ke kō i ke kō me ka alpha-lipoic acid, chromium, ka māiʻuʻu diabolō, fenugreek, kālika, ka gum gum, ka chestnut lio, ginseng Panax, psyllium, ginseng Siberian, a me nā mea ʻē aʻe.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

ʻO ka mahele kūpono o ka melon ʻawaʻawa e pili ana i nā kumu like ʻole e like me ka makahiki o ka mea hoʻohana, olakino, a me nā ʻano ʻē aʻe. I kēia manawa, ʻaʻole lawa ka ʻike ʻepekema e hoʻoholo ai i kahi pae kūpono o nā lāʻau no ka melon ʻawaʻawa. E hoʻomanaʻo i ka pono ʻole o ka palekana i nā huahana kūlohelohe a hiki i nā dosages ke koʻikoʻi. E mālama pono i nā ʻōkuhi pili i nā lepili huahana a nīnau i kāu kauka lāʻau a i ʻole kauka a i ʻole ʻoihana olakino ʻē aʻe ma mua o ka hoʻohana ʻana.

ʻO Cucumber ʻApelika, Ampalaya, Pear Balsam, Balsam-Apple, Balsambirne, Balsamine, Balsamo, ʻĀwī ʻĀʻī, Cucumber ʻawaʻawa, Bitter Gourd, Bittergurke, hua Carilla, Carilla Gourd, Cerasee, Chinli-Chih, Concombre Africaain, Courge Amère, Cundeamor, Fructus Mormordicae Grosvenori, Karavella, Karela, Kareli, Kathilla, Kerala, Korolla, Kugua, Kuguazi, Kʻu-Kua, Lai Margose, Margose, Melón Amargo, Melon Amer, Momordica, Momordica charantia, Momordica murcata, Momordique, Paroka, Pepino Montero , Poire Balsamique, Pomme de Merveille, Pʻu-Tʻao, Sorosi, Sushavi, Ucche, Mea ʻai insulin, Cucumber ʻāhiu.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. Kwak JJ, Yook JS, Ha MS. ʻO nā biomarkers kūpono o ka luhi ākea a me ka luhi waena i nā mea haʻuki hoʻomaʻamaʻa kiʻekiʻe i kahi mahana: kahi aʻo pailaka me Momordica charantia (melon ʻawaʻawa). ʻO J Immunol Res. 2020; 2020: 4768390. Nānā kiʻi ʻole.
2. ʻO Cortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, ʻo González-Ortiz M, ʻo Méndez-Del Villar M. Momordica charantia hoʻokele e hoʻomaikaʻi i ka huna ʻana o ka insulin i ka type 2 diabetes mellitus. J Med Meaʻai. 2018; 21: 672-7. hana: 10.1089 / jmf.2017.0114. Nānā kiʻi ʻole.
3. Peter EL, Kasali FM, Deyno S, et al. Ua hoʻohaʻahaʻa ʻo Momordica charantia L. i ke kiʻekiʻe o ka glycaemia i ka maʻi maʻisuka ʻano ʻelua: Nānā ʻōnaehana a me nā meta-analysis. ʻO J Ethnopharmacol. 2019; 231: 311-24. hana: 10.1016 / j.jep.2018.10.033. Nānā kiʻi ʻole.
4. Soo May L, Sanip Z, Ahmed Shokri A, Abdul Kadir A, Md Lazin MR. Nā hopena o Momordica charantia (melon ʻawaʻawa) hoʻohui i nā mea maʻi me ka osteoarthritis kuli mua: kahi hoʻokolokolo makapō hoʻokahi. Hoʻohui Ther Clin Practice. 2018; 32: 181-6. hana: 10.1016 / j.ctcp.2018.06.012. Nānā kiʻi ʻole.
5. Yue J, Sun Y, Xu J, et al. ʻO Cucurbitane triterpenoids mai ka hua o Momordica charantia L. a me kā lākou anti-hepatic fibrosis a me nā anti-hepatoma hana. ʻOihana Phytochemistry. 2019; 157: 21-7. hana: 10.1016 / j.phytochem.2018.10.009. Nānā kiʻi ʻole.
6. Wen JJ, Gao H, Hu JL, et al. ʻO nā polysaccharides mai Momordica charantia momona i hoʻonui ʻia i ka momona i nāʻiole momona momona i hoʻowalewale ʻia. ʻAla Kūʻai. 2019; 10: 448-57. hana: 10.1039 / c8fo01609g. Nānā kiʻi ʻole.
7. Konishi T, Satsu H, Hatsugai Y, et al. Ka hopena o ka hopena melon ʻawaʻawa ma ka hana P-glycoprotein i nā pūnaewele Caco-2 ʻōpū. ʻO Br J Pharmacol. 2004; 143: 379-87. Nānā kiʻi ʻole.
8. Boone CH, Stout JR, Gordon JA, et al. Nā hopena koʻikoʻi o kahi mea inu me ka mea ʻawaʻawa melon (CARELA) ma ka glycemia postprandial i waena o nā mākua prediabetic. Nutr Diabetes. 2017; 7: e241. Nānā kiʻi ʻole.
9. Alam MA, Uddin R, Subhan N, Rahman MM, Jain P, Reza HM. ʻO ke kūlana maikaʻi o ka hoʻohui melon ʻawaʻawa i ka momona a me nā pilikia e pili ana i ka maʻi metabolic. J Lipids. 2015; 2015: 496169. Nānā kiʻi ʻole.
10. ʻO Somasagara RR, Deep G, Shrotriya S, Patel M, Agarwal C, ʻo Agarwal R. ʻO ka wai wai melon ka pahuhopu i nā hana moleola e pili ana i ke kūpaʻa ʻana o ka gemcitabine i nā hunaola maʻi pancreatic Int J Oncol. 2015; 46: 1849-57. Nānā kiʻi ʻole.
11. Rahman IU, Khan RU, Rahman KU, Bashir M. Lower hypoglycemic akā ʻoi aku ka nui o nā hopena antiatherogenic kiʻekiʻe o ka melon ʻawaʻawa ma mua o glibenclamide i nā maʻi diabetic ʻano 2. Nutr J. 2015; 14: 13. Nānā kiʻi ʻole.
12. ʻO Bhattacharya S, Muhammad N, Steele R, Peng G, Ray RB. ʻO ke kuleana Immunomodulatory o ka melon ʻawaʻawa i ka pāpā ʻana i ka ulu ʻana o ke poʻo a me ka ʻāʻī squamous cell carcinoma. Oncotarget. 2016; 7: 33202-9. Nānā kiʻi ʻole.
13. ʻO Yin RV, Lee NC, Hirpara H, Phung OJ. T. Ka hopena o ka melon ʻawaʻawa (Mormordica charantia) i nā mea maʻi me ka maʻi diabetes: ka loiloi ʻōnaehana a me ka meta-analysis. Nutr Diabetes. 2014; 4: e145. Nānā kiʻi ʻole.
14. ʻO Dutta PK, Chakravarty AK, CHowdhury US, a me Pakrashi SC. ʻO Visin, kahi toxin-inducing mai ka Momordica charantia Linn. na anoano. ʻO Indian J Chem 1981; 20B (ʻAukake): 669-671.
15. Srivastava Y. Antidiabetic a me nā pono adaptogenic o Momordica charantia extract: kahi hoʻokolohua a me ka loiloi loiloi. Phytother Res 1993; 7: 285-289.
16. ʻO Raman A a me Lau C. Nā waiwai anti-diabetic a me ka phytochemistry o Momordica charantia L. (Cucurbitaceae). Phytomedicine 1996; 2: 349-362.
17. Stepka W, Wilson KE, a me Madge GE. Nānā Antifertility ma Momordica. Lloydia 1974; 37: 645.
18. Baldwa VS, Bhandara CM, Pangaria A, a me et al. ʻO nā hoʻokolohua hoʻokolohua i nā mea maʻi me ka maʻi diabetes o kahi lāʻau like like me ka insulin i loaʻa mai ke kumu waiwai. Upsala J Med Sci 1977; 82: 39-41.
19. ʻO Takemoto, D. J., Dunford, C., a me McMurray, M. M. Nā hopena cytotoxic a me nā cytostatic o nā melon ʻawaʻawa (Momordica charantia) ma nā limakū kanaka. Toxicon 1982; 20: 593-599. Nānā kiʻi ʻole.
20. Dixit, V. P., Khanna, P., a me Bhargava, S. K. Nā hopena o Momordica charantia L. hua hua i ka hana testicular a ka ʻīlio. Planta Med 1978; 34: 280-286. Nānā kiʻi ʻole.
21. Aguwa, C. N. a me Mittal, G. C. Nā hopena abortifacient o nā aʻa o Momordica angustisepala. ʻO J Ethnopharmacol. 1983; 7: 169-173. Nānā kiʻi ʻole.
22. Akhtar, M. S. Hoʻokolokolo o Momordica charantia Linn (Karela) pauka i nā mea maʻi me ka oʻo mua o ke kō. ʻO J Pak. Med Assoc 1982; 32: 106-107. Nānā kiʻi ʻole.
23. Welihinda, J., Arvidson, G., Gylfe, E., Hellman, B., a me Karlsson, E. ʻO ka hana hoʻokuʻu insulin i ka mea kanu tropical momordica charantia. ʻO Acta Biol Med Ger 1982; 41: 1229-1240. Nānā kiʻi ʻole.
24. Chan, W. Y., Tam, P. P., a me Yeung, H. W. Ka hoʻopau ʻana o ka hāpai mua ʻana i kaʻiole e beta-momorcharin. Contracéption 1984; 29: 91-100. Nānā kiʻi ʻole.
25. ʻO Takemoto, D. J., Jilka, C., a me Kresie, R. Hoʻomaʻemaʻe a me ke ʻano o kahi mea cytostatic mai ka melon awaawa Momordica charantia. ʻO Biochem 1982; 12: 355-375. Nānā kiʻi ʻole.
26. Wong, C. M., Yeung, H. W., a me Ng, T. B. Ke nānā ʻana iā Trichosanthes kirilowii, Momordica charantia a me Cucurbita maxima (ʻohana Cucurbitaceae) no nā mea hoʻohui me ka antilipolytic hana. ʻO J Ethnopharmacol. 1985; 13: 313-321. Nānā kiʻi ʻole.
27. Ng, T. B., Wong, C. M., Li, W. W., a me Yeung, H. W. Hoʻokaʻawale a me ka hoʻohālikelike ʻana i kahi lektine hoʻopaʻa paʻa galactose me nā hana insulinomimetic. Mai nā hua a ka ʻumeke awaawa Momordica charantia (Family Cucurbitaceae). Int J Peptide Protein Res 1986; 28: 163-172. Nānā kiʻi ʻole.
28. Ng, T. B., Wong, C. M., Li, W. W., a me Yeung, H. W. Nā moleola like insulin i nā hua Momantica charantia. ʻO J Ethnopharmacol. 1986; 15: 107-117. Nānā kiʻi ʻole.
29. Liu, H. L., Wan, X., Huang, X. F., a me Kong, L. Y. Biotransformation o ka sinapic acid i catalyzed e Momordica charantia peroxidase. ʻO J Agric Food Chem 2-7-2007; 55: 1003-1008. Nānā kiʻi ʻole.
30. Yasui, Y., Hosokawa, M., Kohno, H., Tanaka, T., a me Miyashita, K. Troglitazone a me 9cis, 11trans, 13trans-conjugated linolenic acid: hoʻohālikelike o kā lākou antiproliferative a me apoptosis-hoʻokomo i nā hopena ma nā ʻano maʻi ʻaʻai kolona. nā laina pūnaewele. Chemotherapy 2006; 52: 220-225. Nānā kiʻi ʻole.
31. Nerurkar, PV, Lee, YK, Linden, EH, Lim, S., Pearson, L., Frank, J., a me Nerurkar, VR Lipid e hoʻohaʻahaʻa i nā hopena o Momordica charantia (Bitter Melon) i mālama ʻia ʻo HIV-1-protease inhibitor nā hunaola hepatoma kanaka, HepG2. Br J Pharmacol 2006; 148: 1156-1164. Nānā kiʻi ʻole.
32. Shekelle, P. G., Hardy, M., Morton, S. C., Coulter, I., Venuturupalli, S., Favreau, J., a me Hilton, L. K. ʻO nā mea kanu Ayurvedic no ka maʻi kō ka maikaʻi? J Fam.Pract. 2005; 54: 876-886. Nānā kiʻi ʻole.
33. ʻO Nerurkar, P. V., Pearson, L., Efird, J. T., Adeli, K., Theriault, A. G., a me Nerurkar, ʻo V. R. Hoʻomoe ʻia ʻo trigomceride triglyceride huaʻōlelo protein protein a me ka huna ApoB e ka melon ʻawaʻawa i nā pūnaewele HepG2. ʻO J Nutr 2005; 135: 702-706. Nānā kiʻi ʻole.
34. Senanayake, GV, Maruyama, M., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., a me Ohta, H. Nā hopena o nā melon ʻawaʻawa (Momordica charantia) nā huahana ma serum a me ke akepaʻa lipid mau palena i nā hamsters i hānai ʻia i ka ʻai kolesterol a me kaʻai momona. ʻO J Nutr Sci Vitaminol. (Tokyo) 2004; 50: 253-257. Nānā kiʻi ʻole.
35. Kohno, H., Yasui, Y., Suzuki, R., Hosokawa, M., Miyashita, K., a me Tanaka, T. ʻO ka aila huaʻai mea momona i hoʻopili ʻia i ka waika linolenic acid mai ka melon ʻawaʻawa e kāpae i ka carcinogenesis kolona iole azoxymethane. o ka ʻōlelo PPARgamma colonic a me ka hoʻololi o ka hoʻohui lipid. Int J Kanesa 7-20-2004; 110: 896-901. Nānā kiʻi ʻole.
36. Senanayake, GV, Maruyama, M., Shibuya, K., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., a me Ohta, H. Nā hopena o ka melon ʻawaʻawa ( Momordica charantia) ma ke serum a me nā pae triglyceride ate i nā ʻiole. ʻO J Ethnopharmacol 2004; 91 (2-3): 257-262. Nānā kiʻi ʻole.
37. Pongnikorn, S., Fongmoon, D., Kasinrerk, W., a me Limtrakul, P. N. Ka hopena o ka melon awaawa (Momordica charantia Linn) ma ka pae a me ka hana o nā hunaola kūlohelohe i nā maʻi maʻi maʻi maʻi maʻi me ka radiotherapy. ʻO J Med Assoc Thai. 2003; 86: 61-68. Nānā kiʻi ʻole.
38. Rebultan, S. P. Bitter melon therapy: kahi lapaʻau hoʻōla o ka maʻi HIV. ʻO AIDS Asia 1995; 2: 6-7. Nānā kiʻi ʻole.
39. Lee-Huang, S., Huang, PL, Lā, Y., Chen, HC, Kung, HF, Huang, PL, a me Murphy, WJ Inhibition o MDA-MB-231 xenografts puʻupuʻu umauma kanaka a me ka ʻōlelo HER2 e ka anti-tumor nā ʻākena GAP31 a me MAP30. Anticancer Res 2000; 20 (2A): 653-659. Nānā kiʻi ʻole.
40. Wang, YX, Jacob, J., Wingfield, PT, Palmer, I., Stahl, SJ, Kaufman, JD, Huang, PL, Huang, PL, Lee-Huang, S., a me Torchia, DA Anti-HIV a me anti -tumor protein MAP30, he 30 kDa single-strand type-I RIP, kaʻana like i ka hoʻolālā lua a me ka topology beta-sheet me ka kaulahao A o ricin, kahi ʻano-II RIP. ʻO Protein sci. 2000; 9: 138-144. Nānā kiʻi ʻole.
41. Wang, YX, Neamati, N., Jacob, J., Palmer, I., Stahl, SJ, Kaufman, JD, Huang, PL, Huang, PL, Winslow, HE, Pommier, Y., Wingfield, PT, Lee- ʻO Huang, S., Bax, A., a me Torchia, DA ʻO ka hanana Solution o anti-HIV-1 a me anti-tumor protein MAP30: nā ʻike i loko o kāna mau hana he nui. Pūnaewele 11-12-1999; 99: 433-442. Nānā kiʻi ʻole.
42. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): kahi loiloi i ka pono a me ka palekana. ʻO Am J Health Syst Pharm 2003; 60: 356-9. Nānā kiʻi ʻole.
43. ʻO Dans AM, Villarruz MV, Jimeno CA, et al. ʻO ka hopena o ka hoʻomākaukau ʻana o Momordica charantia capsule ma ka kaohi glycemic ma ka type 2 diabetes mellitus e pono ai e aʻo hou. ʻO J Clin Epidemiol 2007; 60: 554-9. Nānā kiʻi ʻole.
44. Shibib BA, Khan LA, Rahman R. ʻO ka hana hypyplylyemia o Coccinia indica a me Momordica charantia i nāʻiole diabetic: kaumaha o nā hepatic gluconeogenic enzymes glucose-6-phosphatase a me fructose-1,6-bisphosphatase a me ke kiʻekiʻe o nā ake a me nā ʻulaʻula. enzyme glucose-6-phosphate dehydrogenase. ʻO Biochem J 1993; 292: 267-70. Nānā kiʻi ʻole.
45. Ahmad N, Hassan MR, Halder H, Bennoor KS. Ka hopena o Momordica charantia (Karolla) nā mea unuhi i ka hoʻokēʻai a me nā pae glucose serum postprandial i nā maʻi NIDDM (abstract). ʻO Bangladesh Med Res Council Bull 1999; 25: 11-3. Nānā kiʻi ʻole.
46. ʻO Aslam M, Stockley IH. Ka launa ma waena o nā mea curry (karela) a me ka lāʻau (chlorpropamide). Lancet 1979: 1: 607. Nānā kiʻi ʻole.
47. Anila L, Vijayalakshmi NR. Nā hopena maikaʻi o nā flavonoids mai Sesamum nunjukkeun, Emblica officinalis a me Momordica charantia. Phytother Res 2000; 14: 592-5. Nānā kiʻi ʻole.
48. ʻO Grover JK, Vats V, Rathi SS, Dawar R. ʻO nā mea kanu anti-diabetic kuʻuna India e hoʻonui i ka holomua o nā hōʻino hōʻino ma nāʻiole diabetic i hoʻokomo ʻia i streptozotocin. ʻO J Ethnopharmacol 2001; 76: 233-8. Nānā kiʻi ʻole.
49. ʻO Vikrant V, ʻo Grover JK, ʻo Tandon N, et al. ʻO ka mālama ʻana me nā extracts o Momordica charantia a me Eugenia jambolana e pale aku i ka hyperglycemia a me ka hyperinsulinemia i nā ʻiole hānai fructose. ʻO J Ethnopharmacol 2001; 76: 139-43. Nānā kiʻi ʻole.
50. Lee-Huang S, Huang PL, Nara PL, et al. MAP 30: kahi mea hoʻopuka hou i ka maʻi HIV-1 a me ka replication. FEBS Lett 1990; 272: 12-8. Nānā kiʻi ʻole.
51. Lee-Huang S, Huang PL, Huang PL, et al. Ka pāpā ʻana o ka integrase o ka maʻi pale maʻi (HIV) ʻano kanaka 1 e nā proteins mea kanu anti-HIV MAP30 a me GAP31. Proc Natl Acad Sci U S A 1995; 92: 8818-22. Nānā kiʻi ʻole.
52. Jiratchariyakul W, Wiwat C, Vongsakul M, et al. ʻO ka mea kāohi iā HIV mai ka ipu ʻawaʻawa Thai. Planta Med 2001; 67: 350-3. Nānā kiʻi ʻole.
53. ʻO Bourinbaiar AS, Lee-Huang S. ʻO ka hana o nā proteins antiretroviral i loaʻa i nā mea kanu MAP30 a me GAP31 e kūʻē i ka maʻi herpes simplex in vitro. ʻO Biochem Biophys Res Commun 1996; 219: 923-9. Nānā kiʻi ʻole.
54. Schreiber CA, Wan L, Sun Y, et al. ʻAʻole ʻona nā antiviral agents, MAP30 a me GAP31, i ka spermatozoa kanaka a pono paha i ka pale ʻana i ka lawe moekolohe ʻana o ka maʻi maʻi pale maʻi maʻi 1. Fertil Steril 1999; 72: 686-90. Nānā kiʻi ʻole.
55. Naseem MZ, Patil SR, Patil SR, et al. ʻO nā hana antispermatogenic a me androgenic o Momordica charantia (Karela) i nā ʻiole albino. ʻO J Ethnopharmacol 1998; 61: 9-16. Nānā kiʻi ʻole.
56. Sarkar S, Pranava M, Marita R. Hōʻike i ka hana hypoglycemic o Momordica charantia i kahi hoʻohālikelike holoholona o ka maʻi kō. ʻO Pharmacol Res 1996; 33: 1-4. Nānā kiʻi ʻole.
57. Cakici I, Hurmoglu C, Tunctan B, et al. Ka hopena Hypoglycaemic o Momordica charantia extract i normoglycaemic a i ʻole cyproheptadine i hoʻokomo ʻia iʻi hyperglycaemic. ʻO J Ethnopharmacol 1994; 44: 117-21. Nānā kiʻi ʻole.
58. Ali L, Khan AK, Mamun MI, et al. ʻO nā haʻawina e pili ana i nā hopena hypoglycemic o ka pulp hua, ka hua, a me nā mea kanu holoʻokoʻa o Momordica charantia ma nāʻiole maʻamau a me nā diabetic. Planta Med 1993; 59: 408-12. Nānā kiʻi ʻole.
59. ʻO ka lā C, Cartwright T, Provost J, Bailey CJ. Ka hopena hypoglycaemic o Momordica charantia extract. Planta Med 1990; 56: 426-9. Nānā kiʻi ʻole.
60. Leung SO, Yeung HW, Leung KN. ʻO nā hana immunosuppressive o nā protein protein abortifacient i hoʻokaʻawale ʻia mai nā ʻanoʻano o ka melon ʻawaʻawa (Momordica charantia). Immunopharmacol 1987; 13: 159-71. Nānā kiʻi ʻole.
61. Jilka C, Strifler B, Fortner GW, a me al. I ka hana vivo antitumor o ka melon awaawa (Momordica charantia). Kaukaha Res 1983; 43: 5151-5. Nānā kiʻi ʻole.
62. Cunnick JE, Sakamoto K, Chapes SK, et al. Ke hoʻokomo ʻana i nā hunaola cytotoxic tumo e hoʻohana ana i kahi protein mai ka melon awaawa (Momordica charantia). Pūnaewele Immunol 1990; 126: 278-89. Nānā kiʻi ʻole.
63. Lee-Huang S, Huang PL, Chen HC, et al. ʻO nā hana anti-HIV a me anti-tumor o ka recombinant MAP30 mai ka melon ʻawaʻawa. ʻO Gene 1995; 161: 151-6. Nānā kiʻi ʻole.
64. ʻO Bourinbaiar AS, Lee-Huang S. Potentiation o ka hana anti-HIV o nā lāʻau anti-inflammatory, dexamethasone a me indomethacin, na MAP30, ka mea antiviral mai ka melon ʻawaʻawa. ʻO Biochem Biophys Res Commun 1995; 208: 779-85. Nānā kiʻi ʻole.
65. Baldwa VS, Bhandari CM, Pangaria A, Goyal RK. ʻO ka hoʻāʻo hoʻokolohua ʻana i nā mea maʻi me ka maʻi diabetes o kahi lāʻau like like me ka insulin i loaʻa mai nā kumuwaiwai. Ups J Med Sci 1977; 82: 39-41. Nānā kiʻi ʻole.
66. Raman A, et al. Nā waiwai anti-diabetic a me nā phytochemistry o Momordica charantia L. (Cucurbitaceae). Phytomedicine 1996; 294.
67. Srivastava Y, Venkatakrishna-Bhatt H, Verma Y, et al. Nā Antidiabetic a me nā adaptogenic waiwai o Momordica charantia extract: kahi hoʻokolohua a me ka loiloi loiloi. Phytother Res 1993; 7: 285-9.
68. Welihinda J, et al. Ka hopena o Momordica charantia ma ke ahonui glucose i ke oʻo ʻana o ka maʻi diabetes. ʻO J Ethnopharmacol 1986; 17: 277-82. Nānā kiʻi ʻole.
69. ʻO Leatherdale B, Panesar RK, Singh G, et al. Hoʻonui i ka hoʻomanawanui ʻana o ka glucose ma muli o Momordica charantia. Br Med J (Clin Res Ed) 1981; 282: 1823-4. Nānā kiʻi ʻole.
70. Blumenthal M, ed. ʻO ke Komikina Kelemania E Monographs: Alakaʻi Therapeutic i nā lāʻau Laʻau. Trans. S. Klein. ʻO Boston, MA: ʻAmelika Botanical Council, 1998.
71. ʻO nā monograps e pili ana i nā lāʻau lapaʻau o nā mea kanu lāʻau. Exeter, UK: ʻEpekema ʻEpekema Co-op Phytother, 1997.

Nānā hope - 11/25/2020